Medline Industries Inc

General

Total Cases58
Active Cases4
Patents120
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
L2
B
PTAB
L4
E
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
09/13/24
RESPONSE in Opposition re [249] MOTION to Compel to Produce 30(B)(6) Corporate Witness on Topic No. 9 to Willful Infringement filed by C.R. Bard, Inc., C.R. Bard, Inc.. (Attachments: # [1] Affidavit of M. Traupman ISO of Bard's Opposition to Medline's Motion to Compel, # [2] Exhibit 1)(Traupman, Matthew) (Entered: 09/13/2024)
09/13/24
RESPONSE in Opposition re [249] MOTION to Compel to Produce 30(B)(6) Corporate Witness on Topic No. 9 to Willful Infringement filed by C.R. Bard, Inc., C.R. Bard, Inc.. (Attachments: # [1] Affidavit of M. Traupman ISO of Bard's Opposition to Medline's Motion to Compel, # [2] Exhibit 1)(Traupman, Matthew) (Entered: 09/13/2024)
09/11/24
ORDER granting [264] Motion for Leave to File Matters Under Seal. THE CLERK IS DIRECTED to seal Plaintiff's Response to Defendants Motion for a Protective Order and Exhibits C, D, E, F and G attached thereto. The documents shall remain under seal until further order of this Court. Signed by Judge J. P. Boulee on 9/11/2024. (gww) (Entered: 09/11/2024)
09/11/24
ORDER granting [264] Motion for Leave to File Matters Under Seal. THE CLERK IS DIRECTED to seal Plaintiff's Response to Defendants Motion for a Protective Order and Exhibits C, D, E, F and G attached thereto. The documents shall remain under seal until further order of this Court. Signed by Judge J. P. Boulee on 9/11/2024. (gww) (Entered: 09/11/2024)
09/10/24
MOTION for Leave to File Matters Under Seal re: [263] Notice of Filing, with Brief In Support by Medline Industries, LP. (Attachments: # [1] Memorandum in Support of Motion, # [2] Exhibit A - Dkt 48 Consent Protective Order, # [3] Text of Proposed Order Granting Motion to File Under Seal)(Kent, Daniel) (Entered: 09/10/2024)
09/10/24
MOTION for Leave to File Matters Under Seal re: [263] Notice of Filing, with Brief In Support by Medline Industries, LP. (Attachments: # [1] Memorandum in Support of Motion, # [2] Exhibit A - Dkt 48 Consent Protective Order, # [3] Text of Proposed Order Granting Motion to File Under Seal)(Kent, Daniel) (Entered: 09/10/2024)
09/10/24
SEALED NOTICE Of Filing by Medline Industries, LP re [262] Response in Opposition to Motion, (Attachments: # [1] SEALED Medline Response to C.R. Bard Inc.'s Motion for Protective Order re Medline's Third Set of RFAs, # [2] Exhibit C - UNDER SEAL, # [3] Exhibit D - UNDER SEAL, # [4] Exhibit E - UNDER SEAL, # [5] Exhibit F - UNDER SEAL, # [6] Exhibit G - UNDER SEAL)(Kent, Daniel) Modified on 9/11/2024 (gww). (Entered: 09/10/2024)
09/10/24
SEALED NOTICE Of Filing by Medline Industries, LP re [262] Response in Opposition to Motion, (Attachments: # [1] SEALED Medline Response to C.R. Bard Inc.'s Motion for Protective Order re Medline's Third Set of RFAs, # [2] Exhibit C - UNDER SEAL, # [3] Exhibit D - UNDER SEAL, # [4] Exhibit E - UNDER SEAL, # [5] Exhibit F - UNDER SEAL, # [6] Exhibit G - UNDER SEAL)(Kent, Daniel) Modified on 9/11/2024 (gww). (Entered: 09/10/2024)
09/10/24
RESPONSE in Opposition re [245] MOTION for Protective Order Regarding Medline's Third Set of Requests for Admission (Nos. 334-808) filed by Medline Industries, LP. (Attachments: # [1] Declaration of B. Thomas Watson, # [2] Exhibit A - List of RFAs from Third Set, # [3] Exhibit B - Bard's Amended Invalidity Contentions, # [4] Exhibit H - Bard's Second Set of Requests for Admission to Medline)(Kent, Daniel) (Entered: 09/10/2024)
09/10/24
RESPONSE in Opposition re [245] MOTION for Protective Order Regarding Medline's Third Set of Requests for Admission (Nos. 334-808) filed by Medline Industries, LP. (Attachments: # [1] Declaration of B. Thomas Watson, # [2] Exhibit A - List of RFAs from Third Set, # [3] Exhibit B - Bard's Amended Invalidity Contentions, # [4] Exhibit H - Bard's Second Set of Requests for Admission to Medline)(Kent, Daniel) (Entered: 09/10/2024)